Apolipoprotein E mimetic peptide COG1410 combats pandrug-resistant Acinetobacter baumannii [PDF]
Frontiers in Microbiology, 2022 The emergence of pandrug-resistant bacteria breaks through the last line of defense and raises fear among people of incurable infections. In the post-antibiotic era, the pharmaceutical field turns to seek non-conventional anti-infective agents ...
Zhiliang Hu
exaly +6 more sources
Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection [PDF]
Nature Communications, 2022 Here, the authors describe a patient with a pandrug-resistant Pseudomonas aeruginosa spinal abscess successfully treated with a personalized combination of phage therapy and antibiotics.
T. Ferry +10 more
doaj +5 more sources
Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae [PDF]
Nature Communications, 2022 In this case study of a patient with fracture-related pandrug-resistant Klebsiella pneumoniae infection after long-term antibiotic therapy, the authors use a combination therapy of pre-adapted bacteriophage and antibiotics resulting in clinical ...
Anaïs Eskenazi +2 more
exaly +3 more sources
Emergence of ST63 Pandrug-Resistant Acinetobacter pittii Isolated From an AECOPD Patient in China [PDF]
Frontiers in Cellular and Infection Microbiology, 2021 Acinetobacter sp. is among the ESKAPE organisms which represent the major nosocomial pathogens that exhibited a high resistance rate. A. pittii, frequently associated with antimicrobial resistance particularly to carbapenems, is one of the most common ...
Ling Yang +5 more
doaj +6 more sources
Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii [PDF]
Antibiotics, 2021 Antimicrobial combinations are at the moment the only potential treatment option for pandrug-resistant A. baumannii. A systematic review was conducted in PubMed and Scopus for studies reporting the activity of antimicrobial combinations against A ...
Stamatis Karakonstantis +3 more
doaj +5 more sources
Bloodstream infection with pandrug-resistant Alcaligenes faecalis treated with double-dose of tigecycline [PDF]
IDCases, 2019 Introduction: Alcaligenes faecalis is a species of gram-negative, rod-shaped, aerobic bacteria commonly found in the environment. A. faecalis-associated nosocomial infections are common in hospitalized patients, but serious life threatening infections ...
Md Jahidul Hasan +2 more
doaj +4 more sources
Pandrug-resistant Acinetobacter baumannii from different clones and regions in Mexico have a similar plasmid carrying the blaOXA-72 gene [PDF]
Frontiers in Cellular and Infection Microbiology, 2023 BackgroundMultidrug-resistant Acinetobacter baumannii is a common hospital-acquired pathogen. The increase in antibiotic resistance is commonly due to the acquisition of mobile genetic elements carrying antibiotic resistance genes. To comprehend this, we
José Luis Fernández-Vázquez +9 more
doaj +2 more sources
Journal of Infection and Public Health, 2021 Background: The upgrowth and rapid prevalence of pandrug-resistant Acinetobacter baumannii strains that have a pathogenic activity to cause several infections are of considerable influence on the health of communities worldwide.
Naiyf S Alharbi
exaly +3 more sources
Isolation, Characterization, Genome Analysis and Host Resistance Development of Two Novel Lastavirus Phages Active against Pandrug-Resistant Klebsiella pneumoniae [PDF]
Viruses, 2023 Klebsiella pneumoniae is a global health threat and bacteriophages are a potential solution in combating pandrug-resistant K. pneumoniae infections.
Mina Obradović +9 more
doaj +2 more sources
A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient [PDF]
Viruses, 2021 Bacteriophages are a promising therapeutic strategy among cystic fibrosis and lung-transplanted patients, considering the high frequency of colonization/infection caused by pandrug-resistant bacteria. However, little clinical data are available regarding
David Lebeaux +19 more
doaj +2 more sources